In HNSCC CK-19 positive CTCs were only detected when enriched using the label-independent Parsortix approach but not in the EpCAM-dependent immunomagnetic CTC enrichment (Fig. 2). The gene discussed is EPCAM; the disease is head and neck squamous cell carcinoma.